Drug Type Biosimilar, Monoclonal antibody |
Synonyms Metreleptin(Genetical Recombination) |
Target |
Mechanism LEPR agonists(Leptin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (25 Mar 2013), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Lipodystrophy | JP | 25 Mar 2013 |